Jonathan P. DiVincenzo - 24 Oct 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
President & COO
Signature
/s/ Jonathan P. DiVincenzo
Issuer symbol
BIO
Transactions as of
24 Oct 2025
Net transactions value
-$322,762
Form type
4
Filing time
28 Oct 2025, 12:29:44 UTC
Previous filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DiVincenzo Jonathan P. President & COO C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Jonathan P. DiVincenzo 27 Oct 2025 0001453524

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +1,869 $0.000000 1,869 24 Oct 2025 Direct F1
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $322,762 -950 -51% $339.75 919 24 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -1,869 -25% $0.000000 5,609 24 Oct 2025 Bio-Rad A Common Stock 1,869 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.